Successful management of a pregnant woman with heterozygous protein C deficiency using activated protein C concentrate
Related Experiment Video
Updated: Aug 30, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Kentaroh Sekiyama1, Hiroaki Itoh, Norimasa Sagawa
1Department of Gynecology and Obstetrics, Clinical Sciences for Pathological Organs, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Heterozygous protein C deficiency frequently causes deep vein thrombosis during pregnancy. We report the successful management of delivery using activated protein C concentrate in a patient with heterozygous protein C deficiency, who developed deep vein thrombosis in mid gestation.
Heterozygous protein C deficiency frequently causes deep vein thrombosis during pregnancy. We report the successful management of delivery using activated protein C concentrate in a patient with heterozygous protein C deficiency, who developed deep vein thrombosis in mid gestation.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care